EF Hutton analyst Tony Butler assumes Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces Price Target of $17.
EF Hutton Assumes Ocean Biomedical at Buy, Announces Price Target of $17
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.